Cita APA

Yu-Wai-Man, P., Carelli, V., Newman, N. J., Tomasso, L., Klopstock, T., Muñoz Negrete, F. J., & Group, L. S. (2024). Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.

Citación estilo Chicago

Yu-Wai-Man, Patrick, Valerio Carelli, Nancy Jean Newman, Livia Tomasso, Thomas Klopstock, Francisco José|||0000-0001-8115-2345 Muñoz Negrete, y LEROS Study Group. Therapeutic Benefit of Idebenone in Patients With Leber Hereditary Optic Neuropathy: The LEROS Nonrandomized Controlled Trial. 2024.

Cita MLA

Yu-Wai-Man, Patrick, et al. Therapeutic Benefit of Idebenone in Patients With Leber Hereditary Optic Neuropathy: The LEROS Nonrandomized Controlled Trial. 2024.